Sodium picosulfate
| Clinical data | |
|---|---|
| Other names | Picosulfuric acid |
| AHFS/Drugs.com | International Drug Names |
| License data | |
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
IUPAC name
| |
| CAS Number |
|
| PubChem CID | |
| DrugBank |
|
| ChemSpider | |
| UNII |
|
| KEGG |
|
| ChEBI |
|
| ChEMBL |
|
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | 100.030.097 |
| Chemical and physical data | |
| Formula | C18H15NNa2O9S2 |
| Molar mass | 499.42 g·mol−1 |
| 3D model (JSmol) |
|
SMILES
| |
InChI
| |
| (what is this?) (verify) | |
Sodium picosulfate (INN, also known as sodium picosulphate) is a contact stimulant laxative used as a treatment for constipation or to prepare the large bowel before colonoscopy or surgery.
It is available as a generic medication.[2]
- ^ Cite error: The named reference
Clenpiq FDA labelwas invoked but never defined (see the help page). - ^ "2022 First Generic Drug Approvals". U.S. Food and Drug Administration (FDA). 3 March 2023. Archived from the original on 30 June 2023. Retrieved 30 June 2023.